On the morning of June 22nd, the National Assembly’s Health and Welfare Committee convened a plenary meeting in Yeouido, Seoul. However, the discussion on the legalization of non-face-to-face treatment was suspended due to conflicting views among legislators. For the past three months, there has been little progress on the issue, and the current non-face-to-face treatment remains a temporary measure introduced during the COVID-19 pandemic.
The Health and Welfare Committee is set to resume discussions on the matter on June 27th. Specifically, the committee will hold the 1st sub-committee for legislative review, focusing on five proposed amendments to the medical law related to non-face-to-face treatment. Some of these proposals include allowing non-face-to-face treatment for returning patients and expanding the scope of non-face-to-face treatment to include first-time patients.
Representative Kang Ki-yoon, chairman of the 1st measure subcommittee and secretary of the ruling party’s Welfare Committee, emphasized the importance of considering the opinions of medical groups and the government in the upcoming meeting. He also highlighted the need to institutionalize the current pilot project.
Under the current regulations, non-face-to-face treatment has been limited to clinic-level medical institutions, with exceptions granted to hospital-level institutions. Additionally, only first-time patients who reside in mountainous areas or face difficulties in traveling are allowed to receive non-face-to-face treatment. This has caused confusion and dissatisfaction among medical professionals, as there is a need to differentiate between first-time and returning patients.
Despite the urgency to institutionalize non-face-to-face treatment, it is anticipated that passing the bill in the upcoming sub-committee meeting will not be an easy task. The ruling party is keen to expedite the process, while opposition lawmakers criticize the government for moving forward with the pilot project without proper National Assembly discussions.
In conclusion, the discussion on the legalization of non-face-to-face treatment will resume in the National Assembly’s Health and Welfare Committee. However, the conflicting views among legislators and the unresolved issues surrounding the pilot project have made the passage of the bill uncertain.
Reporters Hyunah Cha and Sanggon Park, Money Today Reporters | 2023.06.27 06:43
[the300]
[서울=뉴시스] Reporter Choo Sang-cheol = On the morning of the 22nd, a plenary meeting of the Health and Welfare Committee will be held at the National Assembly in Yeouido, Seoul. 2023.06.22. On the 27th, the National Assembly’s Health and Welfare Committee resumes discussions on the legalization of non-face-to-face treatment. This is the first time in three months since the negotiation failed in March. Currently, non-face-to-face treatment, which was introduced temporarily during the COVID-19 pandemic, continues only as a pilot project. This is because there is still a difference of opinion among legislators, and the force for discussion has diminished as a pilot project is already underway.
According to the political cycle on the 26th, the Welfare Committee will hold the 1st sub-committee for legislative review (the 1st Bill sub-committee) on the morning of the 27th and discuss five amendments to the medical law (treatment law non-face-to-face). ) with the main focus on allowing non-face-to-face treatment. In this measure subcommittee, including Democratic Party member Kang Byung-won’s bill, Choi Hye-young’s bill, Shin Hyeon-young’s bill, and Lee Jong-seong’s people’s power bill, which is the agenda at the time of subcommittee the bill on March 21, and People’s Strength legislator Kim Seong-won were included as topics of discussion.
Democratic Party’s Kang Byung-won, Choi Hye-young, and Shin Hyun-young’s bill and People’s Power Congressman Lee Jong-seong’s bill allow non-face-to-face treatment for returning patients. People Power Congressman Kim Seong-won’s plan includes expanding the target of non-face-to-face treatment for first-time patients.
Representative Kang Ki-yoon, chairman of the 1st measure subcommittee and secretary of the ruling party’s Welfare Committee, said in a phone call with Money Today the300, “What do medical groups think at tomorrow’s meeting, and how the government We need to check if we made an effort.” He continued, “We are currently running a pilot project and we need to institutionalize it, so let’s discuss it.”
On the 1st, as the level of emergency alert related to corona infectious diseases has been downgraded from ‘serious’ to ‘warning’, non-face-to-face treatment cannot be carried out according to the Prevention of Infectious Diseases Act. However, given the inconvenience to patients receiving non-face-to-face treatment, it is being continued as a pilot project in accordance with Article 44 of the Framework Act on Health and Medical Care.
Currently, non-face-to-face treatment of the pilot project is targeted at clinic-level medical institutions, but hospital-level medical institutions are also exceptionally allowed to do it. In addition, only first-time patients who live in mountainous areas or have difficulty moving are allowed to receive non-face-to-face treatment as an exception.
However, confusion and dissatisfaction remain in the medical field. In particular, during the COVID-19 period, non-face-to-face treatment was possible for first-time patients, but was limited to returning patients through a pilot project, adding to the need to differentiate between return patients first and second treatment. – patient time before treatment. On the 21st, the Ministry of Health and Welfare also warned that there could be disadvantages such as administrative disposal if the guidelines are repeatedly broken during the pilot project’s guideline period until August.
However, it is not expected that it will be easy to pass the bill in the sub-committee on the 27th. Representative Kang said, “We need to discuss the bill.” Another member of the ruling party’s Welfare Committee said, “It is literally a pilot project, so we need to institutionalize it quickly. “It is true that the campaign is to be passed quickly. has declined.”
Opposition lawmakers disagree with the fact that the government has gone ahead with the pilot project while ‘passing’ the National Assembly discussion. An official from the office of an opposition member who belongs to the Welfare Committee said, “We cannot include the current type of medical care in the bill, and we cannot tell them not to do what is being done in the medical field. Since we started with the pilot project, it became more difficult to negotiate the bill.”
[저작권자 @머니투데이, 무단전재 및 재배포 금지]
#treatment #face #face #legalised…Restart #discussions #National #Assembly #today
